Generalized pustular psoriasis treated with additional biologics after spesolimab: a case series from Japan
Clinical and Experimental Dermatology · 27.01.2026 · 51 (2) · 300-302
DOI: 10.1093/ced/llaf457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 13.10.2025. Verfasst von Chiaki Sasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
This case series from Japan describes three patients with generalized pustular psoriasis who required additional biologic therapies after initial treatment with spesolimab because of persistent erythematous lesions. While spesolimab rapidly resolved pustules and systemic symptoms, complete disease control could not be achieved with acute-phase spesolimab treatment alone, underscoring the need for further data on long-term management strategies.
Autor:innen und Institutionen
- Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.
ORCID-Profile: Kazuki Yatsuzuka
Zitieren
APA
Sasaki, C., Yatsuzuka, K., Kohri, N., Yoshida, S., Nishihara, K., Muto, J., Shiraishi, K., & Fujisawa, Y. (2026). Generalized pustular psoriasis treated with additional biologics after spesolimab: a case series from Japan. Clinical and Experimental Dermatology, 51(2), 300-302. https://doi.org/10.1093/ced/llaf457
Vancouver
Sasaki C, Yatsuzuka K, Kohri N, Yoshida S, Nishihara K, Muto J, et al. Generalized pustular psoriasis treated with additional biologics after spesolimab: a case series from Japan. Clinical and Experimental Dermatology. 2026;51(2):300-302. doi:10.1093/ced/llaf457
BibTeX
@article{Sasaki2026,
author = {Sasaki, Chiaki and Yatsuzuka, Kazuki and Kohri, Nobushige and Yoshida, Satosi and Nishihara, Katsuhiko and Muto, Jun and Shiraishi, Ken and Fujisawa, Yasuhiro},
title = {Generalized pustular psoriasis treated with additional biologics after spesolimab: a case series from Japan},
journal = {Clinical and Experimental Dermatology},
year = {2026},
volume = {51},
number = {2},
pages = {300--302},
doi = {10.1093/ced/llaf457}
}
EUVIMED